Oshrat Harush-Frenkel

1.2k total citations
6 papers, 962 citations indexed

About

Oshrat Harush-Frenkel is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Oshrat Harush-Frenkel has authored 6 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pharmaceutical Science and 2 papers in Biomaterials. Recurrent topics in Oshrat Harush-Frenkel's work include Cellular transport and secretion (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (2 papers). Oshrat Harush-Frenkel is often cited by papers focused on Cellular transport and secretion (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (2 papers). Oshrat Harush-Frenkel collaborates with scholars based in Israel, Germany and United States. Oshrat Harush-Frenkel's co-authors include Simon Benita, Yoram Altschuler, Nir Debotton, Taher Nassar, Jürgen Borlak, Chaim Springer, Maytal Bivas‐Benita, Avraham Avital, Yoav Sherman and Philip Lazarovici and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Biomacromolecules.

In The Last Decade

Oshrat Harush-Frenkel

6 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oshrat Harush-Frenkel Israel 6 469 390 238 231 167 6 962
P. Grenier Canada 10 461 1.0× 401 1.0× 276 1.2× 97 0.4× 108 0.6× 17 908
Andrea Gessner Germany 10 578 1.2× 530 1.4× 319 1.3× 194 0.8× 272 1.6× 11 1.2k
Sunny Kumar India 12 478 1.0× 492 1.3× 383 1.6× 135 0.6× 181 1.1× 36 1.2k
Nir Debotton Israel 7 284 0.6× 227 0.6× 159 0.7× 142 0.6× 123 0.7× 10 642
Anand Kumar Meka Australia 19 406 0.9× 315 0.8× 414 1.7× 481 2.1× 133 0.8× 24 1.2k
Peter P. Wibroe Denmark 12 377 0.8× 361 0.9× 303 1.3× 145 0.6× 175 1.0× 14 996
Archibald Paillard France 9 427 0.9× 254 0.7× 270 1.1× 104 0.5× 118 0.7× 9 695
Dalit Landesman‐Milo Israel 15 310 0.7× 609 1.6× 250 1.1× 132 0.6× 90 0.5× 18 1.1k
Xianzhi Chen China 16 410 0.9× 389 1.0× 378 1.6× 281 1.2× 122 0.7× 34 1.1k
Nathan D. Donahue United States 12 407 0.9× 496 1.3× 475 2.0× 242 1.0× 73 0.4× 16 1.3k

Countries citing papers authored by Oshrat Harush-Frenkel

Since Specialization
Citations

This map shows the geographic impact of Oshrat Harush-Frenkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oshrat Harush-Frenkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oshrat Harush-Frenkel more than expected).

Fields of papers citing papers by Oshrat Harush-Frenkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oshrat Harush-Frenkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oshrat Harush-Frenkel. The network helps show where Oshrat Harush-Frenkel may publish in the future.

Co-authorship network of co-authors of Oshrat Harush-Frenkel

This figure shows the co-authorship network connecting the top 25 collaborators of Oshrat Harush-Frenkel. A scholar is included among the top collaborators of Oshrat Harush-Frenkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oshrat Harush-Frenkel. Oshrat Harush-Frenkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nassar, Taher, et al.. (2011). High Plasma Levels and Effective Lymphatic Uptake of Docetaxel in an Orally Available Nanotransporter Formulation. Cancer Research. 71(8). 3018–3028. 32 indexed citations
2.
Harush-Frenkel, Oshrat, Maytal Bivas‐Benita, Taher Nassar, et al.. (2010). A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery. Toxicology and Applied Pharmacology. 246(1-2). 83–90. 71 indexed citations
3.
Debotton, Nir, et al.. (2009). A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 148–156. 21 indexed citations
4.
Harush-Frenkel, Oshrat, Yoram Altschuler, & Simon Benita. (2008). Nanoparticle-Cell Interactions: Drug Delivery Implications. Critical Reviews in Therapeutic Drug Carrier Systems. 25(6). 485–544. 49 indexed citations
5.
Harush-Frenkel, Oshrat, et al.. (2008). Surface Charge of Nanoparticles Determines Their Endocytic and Transcytotic Pathway in Polarized MDCK Cells. Biomacromolecules. 9(2). 435–443. 330 indexed citations
6.
Harush-Frenkel, Oshrat, Nir Debotton, Simon Benita, & Yoram Altschuler. (2006). Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochemical and Biophysical Research Communications. 353(1). 26–32. 459 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026